Healthy volunteers help uncover drug interactions for new sickle cell treatment
NCT ID NCT06813924
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times
Summary
This study tested whether a new medicine called etavopivat changes how the body processes five common drugs: digoxin, pitavastatin, metformin, midazolam, and rosuvastatin. Thirty-seven healthy adults took etavopivat daily for 10 days along with single doses of each common drug. The goal was to see if etavopivat affects the levels of these drugs in the blood, which helps doctors prescribe them safely together in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON-Salt Lake City
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.